Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection

Shereen Nizari(University College London), M. Francesca Cordeiro(Imperial College Healthcare NHS Trust)
Cell Death and Disease
December 8, 2016
Cited by 69


Related Papers